Advertisement
Table 1 Correlations between PXN expression and clinicopathological characteristics in gastric cancer patients
| PXN expression | ||||
|---|---|---|---|---|
| Characteristics | Total No. | Low No. cases (%) | High No. cases (%) | P value |
| Age | 0.742 | |||
| < 60 | 116 | 75(49.3) | 41(47.1) | |
| ≥ 60 | 123 | 77(50.7) | 46(52.9) | |
| Gender | 0.096 | |||
| Male | 177 | 118(77.6) | 59(67.8) | |
| Female | 62 | 34(22.4) | 28(32.2) | |
| Tumor depth | 0.527 | |||
| T1 | 11 | 9(5.9) | 2(2.3) | |
| T2 | 29 | 20(13.2) | 9(10.3) | |
| T3 | 176 | 109(71.7) | 67(77.0) | |
| T4 | 23 | 14(9.2) | 9(10.4) | |
| Lymph node invasion | 0.656 | |||
| N0 | 55 | 35(23.0) | 20(22.9) | |
| N1 | 85 | 58(38.2) | 27(31.0) | |
| N2 | 64 | 39(25.6) | 25(28.7) | |
| N3 | 35 | 20(13.2) | 15(17.4) | |
| Distant metastasis | 0.001a | |||
| M0 | 173 | 121(79.6) | 52(59.7) | |
| M1 | 66 | 31(20.4) | 35(40.3) | |
| Differentiation status | 0.388 | |||
| Well | 99 | 68(44.7) | 31(35.6) | |
| Moderate | 92 | 55(36.1) | 37(42.5) | |
| Poor and others | 48 | 29(19.2) | 19(21.9) | |
| TNMb stage | 0.021a | |||
| I | 28 | 20(13.1) | 8(9.1) | |
| II | 37 | 23(15.1) | 14(16.1) | |
| III | 100 | 72(47.3) | 28(32.2) | |
| IV | 74 | 37(24.5) | 37(42.6) | |
| Treatment | 0.386 | |||
| Surgery only | 116 | 77(50.7) | 39(44.8) | |
| Surgery + chemotherapy | 123 | 75(49.3) | 48(55.2) | |
| Survival status | 0.004a | |||
| Alive | 98 | 73(48.0) | 25(28.7) | |
| Dead | 141 | 79(52.0) | 62(71.3) | |
